Citigroup’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-49,800
Closed -$376K 6157
2021
Q1
$376K Buy
+49,800
New +$562K ﹤0.01% 3648

Other funds holding CLOV

Citigroup's CLOV Position: Q2 2026 in Review

Citigroup increased its Clover Health Investments (CLOV) stake by 519% in Q2 2026, buying an estimated $636K and bringing the position to 223,265 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #3328.

Citigroup first reported a position in CLOV in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.02M in Q4 2021. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Citigroup held 223,265 shares of Clover Health Investments worth $1.17M as of Q2 2026.
  • Citigroup bought 187,181 Clover Health Investments shares in Q2 2026, an estimated $636K.
  • Clover Health Investments made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3328 holding.
  • Citigroup first reported a position in Clover Health Investments in Q4 2020 and has held it in 23 quarters since.
  • Citigroup's Clover Health Investments position peaked at $3.02M in Q4 2021.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.